El análisis de las células provenientes de varios pacientes con mutaciones en ATAD3 reveló que las mitocondrias y su ADN presentan algunas alteraciones estructurales y que el colesterol celular est...
Read moreyzon Genomics, a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with a strong unmet medical need, today reported financial results for the fourth quar...
Read moreARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs backed by Columbus Venture Partners, has announced that the ...
Read moreEl grupo ‘Bases Moleculares de los Sistemas Biológicos’ de la Universidad de Málaga (SIBIUMA) forma parte del proyecto internacional ‘EURAS’, que avanza en el estudio de las RASopatías, uno...
Read moreIn the fight against these diseases, at IRB Barcelona, they are committed to interdisciplinary research through new projects aimed at better understanding rare diseases and developing new therapies an...
Read moreIt has been demonstrated in animal models the benefits of vorinostat after having suffered a stroke. The drug, used in humans to treat cutaneous T-cell lymphoma, has been proved to mitigate brain inju...
Read moreEl Servicio de Neurología del Hospital Universitario Virgen Macarena coordina un proyecto multicéntrico para desarrollar una nueva herramienta que permita el diagnóstico rápido de ictus isquémico...
Read moreUn estudio liderado por el CSIC ayuda a detectar y analizar las oscilaciones rápidas, biomarcadores relacionados con la memoria, la epilepsia o el alzhéimer
Read moreA research team led by the Institut de Neurociències at the UAB has managed to generate and validate a new animal model. This model enables the examination of the initial phases of Parkinson's diseas...
Read moreBraingaze, the University of Barcelona’s digital cognitive health spin-off, successfully closed a €1.5 million investment round. The funding will accelerate the clinical and business development o...
Read moreIt has been shown that patients with schizophrenia and bipolar disorder have altered oligodendroglial cells (specifically, the expression levels of the discoidin domain receptor 1 or DDR1 gene, for it...
Read moreA research team from the Institut de Recerca Sant Joan de Déu · SJD Barcelona Children’s Hospital is participating in an international clinical trial of a gene therapy for Duchenne muscular dystro...
Read more